Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction

0301 basic medicine Podocytes Cystinosis Kidney Glomerulus Apoptosis Radboudumc 11: Renal disorders RIMLS: Radboud Institute for Molecular Life Sciences Article 3. Good health Kidney Tubules, Proximal Disease Models, Animal Gene Knockout Techniques 03 medical and health sciences Amino Acid Transport Systems, Neutral Phenotype Mutation Journal Article Animals Cystine Humans Amino Acid Sequence Lysosomes Locomotion Zebrafish Glomerular Filtration Rate
DOI: 10.1038/srep42583 Publication Date: 2017-02-15T10:20:51Z
ABSTRACT
AbstractThe human ubiquitous protein cystinosin is responsible for transporting the disulphide amino acid cystine from the lysosomal compartment into the cytosol. In humans, Pathogenic mutations of CTNS lead to defective cystinosin function, intralysosomal cystine accumulation and the development of cystinosis. Kidneys are initially affected with generalized proximal tubular dysfunction (renal Fanconi syndrome), then the disease rapidly affects glomeruli and progresses towards end stage renal failure and multiple organ dysfunction. Animal models of cystinosis are limited, with only a Ctns knockout mouse reported, showing cystine accumulation and late signs of tubular dysfunction but lacking the glomerular phenotype. We established and characterized a mutant zebrafish model with a homozygous nonsense mutation (c.706 C > T; p.Q236X) in exon 8 of ctns. Cystinotic mutant larvae showed cystine accumulation, delayed development, and signs of pronephric glomerular and tubular dysfunction mimicking the early phenotype of human cystinotic patients. Furthermore, cystinotic larvae showed a significantly increased rate of apoptosis that could be ameliorated with cysteamine, the human cystine depleting therapy. Our data demonstrate that, ctns gene is essential for zebrafish pronephric podocyte and proximal tubular function and that the ctns-mutant can be used for studying the disease pathogenic mechanisms and for testing novel therapies for cystinosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (63)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....